TheBrief.Health

New Hope for Liver Fibrosis Treatment


Listen Later

McMaster researchers report EVT0185 may prevent and reverse liver fibrosis by targeting metabolism, offering a promising therapy for MASH with clinical trials expected by 2027.
...more
View all episodesView all episodes
Download on the App Store

TheBrief.HealthBy TheBrief.Health